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Elevated cytosolic calcium of adipocytes in chronic renal failure.
Chronic renal failure (CRF) is associated with increased calcium content
of, and impaired lipase release from lipid cells. This has been attributed to
a rise in the cytosolic calcium ([Ca2]i) of these cells. However, data on
[Ca2Ii of lipid cells in CRF and on the mechanisms responsible for such
an abnormality are lacking. To study this issue we examined the [Ca2]i
and ATP content of lipid cells and Vmax of Na-K-ATPase and Ca2
ATPase of membrane preparation and Na-Ca2 exchange of membrane
vesicles of adipocytes from normal rats, 6 week CRF, CRF normocalcemic
parathyroidectomized (CRF-PTX) and CRF, and normal rats treated with
verpamil (CRF-V, normal-V). [Ca2Ii in adipocytes of CRF rats was
higher (199 8.5 nM) and ATP lower (2.9 0.31 nmol/106 cells) than in
normal (120 4.3 nM; 5.7 0.27 nmol/106 cells), CRF-PTX (128 4.7
nM; 5.8 0.39 nmol/10' cells), normal-V (121 3.2 nM; 5.3 0.36
nmol/106 cells), CRF-V (123 7.4 nM; 5.5 0.30 mnol/106 cells). Vm
Ca2ATPase and the activity of Na-K-ATPase and of Na*Ca2±
exchanger were reduced in CRF rats as compared to the other four groups
of rats. The values in normal, CRF-PTX, CRF-V and normal-V rats were
not different. These results indicate that: (1) in CRF, adipocytes are
overloaded by calcium; (2) this abnormality is mediated by the secondary
hyperthyroidism of CRF since PTX of CRF rats or interference with the
action of PTH by a calcium channel blocker prevented these changes; and
(3) the elevation in [Ca2]i is due to both increased entry of calcium into
adipocytes and a decreased extrusion out of these cells.
Abnormalities in lipid metabolism are commonly encountered
in chronic renal failure (CRF). Indeed, CRF is associated with
hyperlipidemia [1—3] due in major part to impaired removal of
triglycerides from plasma [3, 4]. It has been shown that the
post-heparin lipolytic activity is reduced [1, 4] and the removal of
intravenous lipid load is impaired [4, 5] in CRF. Akmal et al [6]
found that these abnormalities are mediated in major part by the
state of secondary hyperparathyroidism of CRF. They demon-
strated that parathyroidectomy of CRF rats maintained normo-
calcemic prevented these derangements.
PTH enhances entry of calcium into adipocytes [7], and chronic
excess of PTH in CRF is associated with increased calcium
content of epididymal fat pads of rats [6]. This latter abnormality
appears to play an important role in the deranged lipid metabo-
lism of CRF, since the prevention of calcium accumulation in
adipose tissue by treatment of CRF animals with verapamil
corrected the hyperlipidemia and normalized the post-heparin
lipolytic activity and the abnormal removal of intravenous lipid
loads [6].
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Increased calcium content of other tissues in CRF [8—10] is
usually associated with an elevation in the basal levels of [Ca24]i
in the cells of these tissues [11—13], and such a change mediates
the dysfunction of cells in CRF [14]. It is possible, therefore, that
the basal levels of [Ca2]i of adipocytes are also elevated in CRF.
The present study examined the basal levels of [Ca2]i of
adipocytes in CRF, evaluated the role of excess PTH in the
genesis of such an abnormality and explored the mechanisms that
lead to a rise in the basal levels of [Ca2]i of adipocytes in CRF.
Methods
A total of 212 Sprague-Dawley rats weighing 360 to 450 g were
used. These animals are used in the study published by us [11].
However in that publication we reported data on the myocardium
while in this paper we examine adipocytes. We do not believe that
this fact has an adverse effect on the results of the current study,
since it is not inappropriate to also use the same animals for the
investigation of metabolism of another organ especially when the
number of animals is very large. Such an approach saves time and
research funds. The animals were housed in individual cages and
fed normal rat chow (Wayne Research Animal Diets, Chicago, IL,
USA) throughout the study. The diet contained 1.4% calcium,
0.97% phosphorus, and 4.4 IU of vitamin Dig. Studies were
performed in 5 groups of animals: (1) normal rats, (2) rats with
CRF of 6 weeks duration, (3) normocalcemic parathyroidecto-
mized CRF rats (CRF-PTX) of 6 weeks duration, (4) CRF rats of
6 weeks duration treated with verapamil (0.1 gIg body wt) which
was given subcutaneously twice a day form day one of CRF,
(CRF-V), and (5) normal rats treated with verapamil, as de-
scribed above for 6 weeks (normal-V).
CRF was produced by 5/6 nephrectomy; the animals underwent
right 2/3 nephrectomy through a flank incision and a week later, a
left nephrectomy was done. PTX was performed by electrocau-
tery, and the success of the procedure was ascertained by a
decrease in plasma levels of calcium of at least 2 mg/dl. The PTX
rats were allowed to freely drink water containing 5% calcium
gluconate. This procedure is adequate to normalize serum cal-
cium in the PTX rats. Seven days after PTX, the rats were
subjected to 5/6 nephrectomy as described above. Two days before
sacrifice, the animals were housed in metabolic cages and two
consecutive 24-hour urine collections were obtained for the
measurement of creatinine clearance. The animals were killed by
decapitation on day 42 after the completion of the 5/6 nephrec-
tomy in CRF rats (CRF, CRF-PTX, CRF-V) or after the begin-
ning of the treatment with verapamil in normal rats.
Isolation of adipocytes was done according to the method of
Rodbell [151. After the sacrifice of the animals, the epididymal fat
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pads were removed, washed with normal saline and cut into small
pieces. The tissue was then placed in 50 ml polypropylene tube
containing 8 ml of Krebs-Ringer bicarbonate (KRB) solution (137
mM NaC1, 2.7 mM KC1, 0.5 mrvt MgC12 12 mtvt, NaHCO3, 4 mM
NaH2PO4, 1.4 mM CaC12), 5 mg collagenase type 1 (Worthington
Biochemical, Freehold, NJ, USA), 3 mo1 glucose/ml and 4%
BSA, pH 7.4. The mixture was incubated in a shaking water bath
(37°C) for one hour and then passed trough mesh nitex screen
(Tetko, Elmsford, NY, USA). The filtrate was centrifuged at 400
g for two minutes and the floating adipocytes were picked by a
pipette and transferred to KRB medium. The tubes containing the
adipocytes were shaken gently each time before centrifugation,
and any fat droplets that might have been formed from leakage of
the fat cells floated rapidly to the surface. They were then picked
up by a transferring pipette. After the final centrifugation, the
adipocytes floated to the top of the KRB solution. The pH of the
KRB solution throughout the procedure was monitored and kept
at 7.4. The intactness of the cells was confirmed by microscopy as
described by us previously [7].
[Ca2]i of adipocytes was measured with Fura2-AM (Sigma
Chemical Co., St. Louis, MO, USA). An aliquot of I ml of the
floating layer of adipocytes was added to 8 ml of KRB solution
containing Fura 2 at a concentration of 4 tM. The mixture was
incubated in a shaking bath (37°C) for 40 minutes; it was then kept
at room temperature for 30 minutes followed by washing three
times with Krebs-Hepes buffer (118 mM NaCI, 5 mvt KCI, 1.2 mM
MgCl2, 1.2 mrvi KH2PO4, 1.25 mr'i NaHCO3, 20 mrvi Na Hepes, 5
mg/mi BSA, and 0.3 mg/dl glucose, pH 7.4) and centrifugation at
400 g for two minutes. Fat droplets that might have been formed
were removed as described above, Fluorescence was measured
with a Perkin-Elmer fluorometer model LS5B (Perkin-Elmer,
Norwalk, CT, USA) at excitation wavelengths of 340 and 380 nm
and emission wavelength of 510 nm. The maximal (Frnax) and the
minimal (F,) fluorescence were estimated as previously re-
ported [7, 13]. The cuvette containing the loaded cells was shaken
gently and the fluorescence was recorded immediately. The cells
were lysed with Triton-X (0.05%) to obtain the This
concentration of Triton-X does not produce fluorescence. Next,
40 d of EGTA in 3 M base buffer (pH 8.5) were added to obtain
Fmin. To determine the effect of autofluorescence due to cuvette
medium and adipocytes, the fluorescence was measured with an
empty cuvette, after the addition of the medium and after the
addition of the cells without Fura 2. The unloaded adipocytes
generated small amounts of fluorescence. Correction for autofluo-
rescence of the cuvette, medium, and adipocytes was made by
setting the fluorometer on autozero before each measurement.
Calculation of [Ca2]i was made using the Grynkiewicz equation
[161. The dissociation constant for Ca2-Fura 2 was assumed to be
225 flM [16].
The ATP content of adipocytes was determined by the method
of Lundin et al [171 using a firefly luminescence assay with LAD
535 luminometer (Turner Design, Sunnyvale, CA, USA). The
details of this assay were described previously by us [12]. Adipo-
cytes were counted under the microscope in the 50 in aliquot used
for the measurement of ATP. The value of ATP was then
expressed in 106 cells.
Measurement of Na-K-ATPase and Ca2 ATPase activities
were made using plasma membranes prepared from adipocytes
according to the method described by Resh [18]. The adipocytes
obtained from one to two rat epididymal fat pads were suspended
in 35 ml of homogenization buffer (225 m sucrose, 20 mM
Tris-HC1, 1 msi EDTA, pH 7.4) and homogenized in a polytron
homogenizer (Kinematic Instrument, Switzerland) 10 times for 5
seconds each at 1200 rpm. The homogenate was centrifuged at
16000 g for 15 minutes. The pellet was saved, resuspended in
homogenization buffer and spun once again at 16000 for 15
minutes. The final pellet was resuspended in 2 ml of homogeni-
zation buffer and layered over 3 ml of 33.5% (wt/wt) sucrose in 20
mM Tris-HC1, 1 mivi EDTA, pH 7.4. Following centrifugation for
one hour at 70000 g in an Ti 50 rotar using Beckman LS 5
ultracentrifuge (Beckman Instrument, Palo Alto, CA, USA), the
plasma membranes band at the sucrose gradient interface was
saved and washed in buffer containing 20 mrvi Tris-HC1, 1 mM
EDTA, pH 7,4 and spun at 50000 g for 30 minutes using the same
rotor. The final plasma membrane pellet was resuspended in
Hepes-Mg buffer containing 100 mrvi Hepes-Tris, 5 mi MgC12, pH
7.4 giving the final protein concentration of 1.5 to 3.0 mg/mI. The
preparation was stored at —70°.
For the measurement of Na-K-ATPase, 50 id of the plasma
membranes preparation were added to 900 d of medium con-
taining 50 mi Tris-HC1 (pH 7.4), 1 mtvi EDTA and 4 mivi MgCl2
in the presence and absence of 100 mrvi NaCl and 10 mrvi KCI. The
medium with NaC1 and KC1 contained 2 mrvi ouabain. Both
samples were pre-incubated for five minutes at 37°C; thereafter,
50 nl of 80 m of Tris ATP were added to the mixtures to give a
final concentration of 4 mi ATP. The mixtures were incubated in
a water bath for 20 minutes at 37°C. The ATP levels were
measured by the firefly luciferase luminescence technique using
LAD 535 luminometer [17] before and at the end of the 20 minute
incubation. The values of Na-K-ATPase activity were calcu-
lated as the difference between the ATP levels consumed by the
plasma membranes during the 20 minute incubation in the
presence and absence of NaCI and KC1.
The plasma membrane Ca2 ATPase activity was determined
by continuous monitoring of ATP consumption using the firefly
luciferase luminescence technique [17]. An aliquot of 50 ul of the
plasma membranes was added to 900 id of medium containing
160 ms KCI, 20mM MOPS, 5 mrvi MgCl2, 5 mivi NaN3 and 0.2 mvi
EGTA without calcium and with two concentrations of calcium of
0.162 and 0.181 mt, that were equivalent to 1.0 and 2.0 fLM free
calcium, respectively. For the determination of free calcium
concentration, the association constant of 4.47 >< 106 was used for
Ca2-EGTA binding [19]. At the end of five minutes pre-
incubation at 37°C, 50 jd of 20 m of Tris-ATP were added to the
mixtures giving a final volume of 1 ml and a concentration of ATP
of 1 mtvi. The mixtures were incubated for 20 minutes at 37°C. The
Ca2 ATPase activity was calculated as the difference between the
ATP consumption in the presence and absence of calcium. The
activity of the enzyme at these two concentrations of calcium were
not different; thus, the values obtained represent the Vmax of the
Ca2 ATPase.
For the measurement of Na-Ca2 exchange, membrane vesi-
des were prepared according to the method described by Jarett
[20]. The Na-Ca2 exchange was estimated as Na -dependerit
45Ca uptake by a modification of the method described by
Bersohn et al [21]. An aliquot of 5 pJ of NaC1-loaded vesicles was
added to 245 cd of uptake medium containing 160 mrvi KCI, 45Ca
0.3 MCi (specific activity 10 to 40 mCi/mg calcium, Amersham,
Arlington Heights, IL, USA), 10 MM CaCl2, 20 mivi MOPS (pH
7.4). After different times of 5, 10, 15, 30, 60, and 90 seconds, 30
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p1/min/100 gCreatinine Calcium Phosphorus
Normal 36 397 9.2 0.32 0.01 9.0 0.1 6.6 0.2 17 1.9 536 16
Studies at 6 weeks
CRF 34 397 7.0 1.30 0.01 8.7 0.2 6.8 0.3 54 6.6a 165 6
CRF-PTX 31 401 6.6 1.01 0.03 8.6 0.2 6.8 0.2 11 4.3 162 ua
CRF-V 32 408 8.0 1.02 0.01 9.0 0.2 6.7 0.3 49 47a 159 ioa
Normal-V 32 387 5.0 0.33 0.01 8.9 0.2 6.9 0.5 20 4.6 546 13
Data are presented as mean SE. These animals are part of the animals reported in Kidney mt 45:1113—1119, 1994 for the study of cardiac myocytes.
Therefore, the biochemical data are similar to those reported earlier. However, in the current study we examined the metabolism of another tissue
(adipocytes).
a P < 0.01 vs. other groups
jil of 10 mrvi EGTA (pH 7.4) were added, followed by 1 ml of
ice-cold 1 mvi EGTA-KC1-MOPS to stop the reaction. An aliquot
of 1 ml was then taken from the mixture and passed through
millipore membrane filter (0.45 jim, Millipore Corp., Bedford,
MA, USA). The membranes were subsequently washed twice in 2
ml of ice-cold 1 ms't EGTA-KC1-MOPS. The membranes were
then placed in scintillation vials containing 10 ml of scintillation
fluid (Ecolite, ICN Biochemicals, Irvine, CA, USA) and counted
with Beckman LS 7000 scintillation counter. K-Ioaded vesicles
were treated in a similar manner. The Na-Ca2 exchange was
calculated as the difference between the uptake by NaCI-loaded
vesicles and KCI-loaded vesicles.
The measurement of calcium in the plasma was made by
Perkin-Elmer atomic absorption spectrophotometer, model 503,
and those of plasma creatinine and phosphorus and urine creat-
mine by an autoanalyzer (Technicon Instrument Crop., Tarry-
town, NY, USA). The serum levels of PTH were determined by an
INS-PTH immunoassay kit (Nichols Institute Diagnostics, San
Juan Capistrano, CA, USA). This assay recognizes the aminoter-
minal fragment of PTH. The lowest detectable level is 3 pglml; the
interassay variations is 7.3% and the intrassay variations 4%.
Protein content of the sarcolemmal vesicles was measured by the
method of Bradford [22].
Statistical analysis was done by one-way analysis of variance
(ANOVA) and significant differences with Bonferroni-Dunn test
for multiple comparison between the groups. Data are presented
as mean 1 SE.
Results
Table 1 provides the effects of the various experimental proce-
dures on body weight, plasma concentration of creatinine, calcium
and phosphorus, and serum levels of PTH and creatinine clear-
ance. There were no significant differences in body weight and the
plasma concentrations of calcium and phosphorus among the five
groups of rats. The plasma concentrations of creatinine were
significantly (P < 0.01) higher and the creatinine clearances were
significantly (P < 0.01) lower in CRF, CRF-PTX and CRF-V rats
than in normal and normal-V animals. There were no significant
differences between these parameters among CRF, CRF-PTX
and CRF-V rats. The serum levels of PTH were significantly (P <
0.01) higher in CRF and CRF-V rats than in normal, normal-V
and CRF-PTX animals.
Figure 1 depicts the data on the basal levels of [Ca2]i in all
groups of animals. The [Ca21i in adipocytes from CRF animals
(199 8.5 nM) was significantly (P < 0.01) higher than that in
adipocytes from normal rats (120 4.3 nM). PTX of CRF rats or
E I 0







Normal CRF CRF-PTX CRF-VER NOR-VER
Fig. 1. Basal levels of cytosolic calcium in
CRF-PTX, CRF-V and normal-Vrats. Each da
and brackets denote 1 SE.
adipocytes of normal, CRF,
turn point represents one rat
their treatment with verapamil prevented the rise in [Ca21i of
adipocytes. Indeed, the basal levels of [Ca2Ii in adipocytes from
CRF-PTX rats (128 4.7 nM) and in CRF-V (123 7.4 nM) were
not different from normal. The treatment of normal rats with
verapamil did not alter the [Ca2ji of their adipocytes (121 3.2
nM).
The ATP content of adipocytes after six weeks of CRF (2.92
0.31 nmol/106 cells) was significantly (P < 0.01) lower than that
observed in normal rats (5.7 0.27 nmol/106 cells; Fig. 2). The
values of ATP content in the CRF-PTX (5.84 0.39 nmol/106
cells), CRF-V (5.30 0.36 nmol/106 cells) and normal-V (5.50
0.3 nmol/106 cells) rats were not different from those in adipocytes
of normal rats.
The values of the V,ax of Ca2 ATPase are depicted in Figure
3. The activity of this enzyme in the adipocytes from CRF rats
(1.96 0.11 jimol Pi/mg protein/hr) was significantly (P < 0.01)
lower than that in normal animals (2.82 0.16 jimol Pi/mg
protein/hr). PTX of CRF rats and their treatment with verapamil
prevented the reduction of the Vmax of the Ca2 ATPase with the
values being 3.08 0.21 and 2.95 0.18 jimol Pi/mg protein/hr,
respectively. The values in normal-V rats (3.15 0.27 jtmol Pi/mg
protein/hr) were not different from normal.
Similarly, the activity of Na-K-ATPase of adipocytes from
CRF rats (10.6 0.97 jimol P1/mg protein/hr) was significantly (P
<0.01) lower than that in normal animals (15.7 1.0 jimol Pi/mg
protein/hr; Fig. 4). Again the values were normalized by PTX of












Normal CRF CRF-PTX CRF-VER NOR-VER
Fig. 4. The activity of Na-K-ATPase of adipocytes from normal, CRF,
GRF-PTX, GRF-Vand normal-Vrats. Each datum point represents one rat
and brackets denote I SE.
with verapamil (14.9 0.92 j.tmol Pi/mg protein/br) and values
were not different from normal ones.
The Na-dependent 45Ca uptakes by adipocytes membrane
vesicles in all groups of animals studied are shown in Figures 5
and 6. Only CRF animals displayed significantly lower levels of
uptake (P < 0.01) during 30 to 120 minutes of the uptake study.
The values of the Na-Ca2 exchange are shown in Table 2.
These values in CRF animals were significantly (P < 0.01) lower
Fig. 5. Time course of Na-dependent 45Ca uptake by membrane vesicies of
adipocytes from 10 normal (0), 12 CRF (•), 7 CRF-PTX (fIll), 9 CRE-V
(0), and 9 normal-V (A) rats. Each datum point represents the means of
-studies. and brackets denote 1 Se. The uptake by KCI loaded vcsicles
(U) is also shown.
than in all other groups of rats. The values of Na-Ca2 exchange
among the normal, CRF-PTX, CRF-V and normal-V were not
different.
Discussion
The data of the present study show that the basal levels of
[Ca2]i of adipocytes from rats with CRF are markedly and
significantly higher than values observed in adipocytes of normal
animals. Two observations in our study indicate that this derange-
ment is due to the state of secondary hyperparathyroidism of
CRF. First, the values of [Ca21]i in adipocytes of CRF-PTX
animals maintained normocalcemic are normal. Second, the treat-
ment of CRF-rats with verapamil, an agent that interferes with the
PTH-induced calcium entry into adipocytes [7], also prevented the
rise in their [Ca2]i.
Our findings in adipocytes of CRF-rats are similar to previous
observations in other cells. Indeed, CRF is associated with a rise
in basal levels of [Ca2 Ji in pancreatic islets [12], polymorphonu-
clear leukocytes [23], brain synaptosomes [13], /3 cells [24], T cells
[25], thymocytes [26], platelets [27] and cardiac myocytes [11]. In
all these cells, the elevation in their [Ca2]i was also due to the
sustained elevation in the blood levels of PTH. It is evident that
the state of secondary hyperparathyroidism of CRF induces a
generalized increase of [Ca2]i of cells and such an abnormality
contributes in major part to the organ dysfunction in uremia [14].
Hypertriglyceridemia and fat intolerance exist in CRF humans
[1—3, 5] and animals [4, 6]. This abnormality is in major part due
to reduced peripheral clearance of triglycerides secondary to
impaired lipolytic activity [4, 61. Akmal et a! [6] showed that PTX
or verapamil therapy of CRF rats prevented the derangements in
their triglyceride metabolism. It is, therefore, reasonable to
propose that the elevation in the basal levels of [Ca2]i of
adipocytes interferes with the synthesis and/or release of their



















Normal CRF CRF-PTX CRF-VER NOR-VER
Fig. 2. A TP content of adipocytes from normal, CRE, CRE-PTX, GRE-V

















Normal CRF CRF-PTX CRF-VER NOR-VER
Fig. 3. The V,,,, of Ca2 ATPase of adipocytes from normal, GRE,
CRE-PTX, CRF-Vandnormal-Vrats. Each datum point represents one rat













Table 2. Na-Ca2 exchange by plasma vesicles of adipocytes from




30 seconds 90 seconds
Normal 10 1.07 0.05 1.74 0.11
CRF 12 0.56 0.osa 0.86 0.04
CRF-PTX 7 1.09 0.09 1.58 0.11
CRF-V 9 0.79 0.05 1.63 0.09
Normal-V 9 1.18 0.10 1.80 0.11
Data are presented as mean 1 SE.
a P < 0.01 vs. other groups
PTH increases calcium entry into adipocytes in a dose depen-
dent manner [7], and this action of the hormone could be
responsible for the elevation in [Ca2Ii of adipocytes when the
cells are exposed to chronic excess of PTH as in CRF. However,
augmented entry of calcium into cells is not adequate to cause a
sustained rise in their [Ca2]i since cells are endowed with
powerful pumps that permits the extrusion of excess calcium out
to the cells [28]. Three processes participate in pumping calcium
out of cells. These are Ca2 ATPase, Na-Ca2 exchange and
Na-K-ATPase. Our data show that activity of all these pumps
is reduced in CRF. Thus, it appears that both increased influx into
and decreased efflux out of the adipocytes are responsible for the
rise in basal levels of their [Ca2Ii.
Chronic and sustained entry of calcium into cells is associated
with inhibition of mitochoodrial oxidation, and hence reduced
ATP production [29 —311. Indeed, our data show the ATP content
of adipocytes from CRF rats is significantly lower than that of
adipocytes from normal rats. Both Ca2 ' ATPase and Na-K
requires ATP [28, 32] and the fall in ATP content of adipocytes is,
at least partly, responsible for the decreased activity of this
enzyme.
It could be argued that the affinity of Na -K-ATPase for ATP
is in the micromolar range, and therefore, the decrease in ATP
content observed in our study is not adequate to adversely affect
the activity of the enzyme. It should be mentioned, however, that
Niki et al [32] reported that Na -K-ATPase activity in HIT-TIS
13 cells was progressively inhibited as ATP concentration was
lowered from 3.0 to 1.5 mrvt. It is possible that compartmentaliza-
tion of ATP may exist within adipocytes with the concentration of
ATP in the submembrane pool is considerably lower than in other
Fig. 6. A schematic presentation of the sequence
of events that lead to the elevation in [Ca2 ]i of
adipocytes. All steps have been tested in the
present study or in a previous study [7] from
our laboratosy. It should be noted that
treatment of CRF animals with verapamil, by
blocking the continued PTH-mediated entry of
calcium into the adipocytes, removes the
mechanism that leads to inhibition of
mitochondrial oxidation. Consequently, the
ATP production returns to normal. This figure
does not imply that the reduction in ATP
affects the Na-Ca2 exchanger, and the
mechanism for the inhibition of this exchanger
is discussed in the text.
cytosolic pools of ATP. Under such circumstances a decrease in
ATP concentration in the vicinity of cell membrane could affect
the activity of Na-K-ATPase and Ca2 ATPase.
One should also consider that other consequences of CRF or
alterations in cell membrane, such as derangements in their
phospholipids content, may also contribute to the impaired activ-
ity of these enzymes. Indeed, phospholipids of cell membrane are
reduced in CRF [33].
The changes in the activity of Na-K-ATPase and Ca2
ATPase could be due to a reduction in the number of enzyme
units per cell, in the activity of each enzyme unit or both. Our data
do not differentiate between these alternatives. However, the data
of Greiber et al [34] in adipocytes of CRF rats is consistent with
the inhibition of the activity of Na-K-ATPase. They found that
in adipocytes of CRF rats, the intracellular sodium is increased,
ouabain-binding is reduced but immunoreactive a and /3 subunits
of Na-K-ATPase are not depressed.
It is apparent from the above discussion that the initial event
leading to the rise in [Ca2]i is the PTH-induced entry of calcium
in the adipocytes. This action would then trigger other cellular
events that lead to a decrease in calcium extrusion. This sequence
of events is presented schematically in Figure 6. This formulation
is supported by the findings that both PTX of CRF rats which
abolishes the state of secondary hyperparathyroidism or their
treatment with verapamil, which blocks the PTH-mediated entry
of calcium into cells, prevented the reduction in ATP content of
adipocytes and the impairment in the activity of the pumps
responsible for the calcium extrusion out of these cells. Thus,
neither PTH per se (CRF-V rats) nor CRFper se (CRF-PTX rats)
generate the abnormalities in ATP and in the activity of Ca2
ATPase, Na-K-ATPase and Na -Ca2 exchange.
The factors that may modulate the Na -Ca2 exchange of
adipocytes are not well understood. It is possible that CRF or a
metabolic consequence of CRF is associated with inhibition of the
activity of the Na -H antiport, an event that would result in a
decreased entry of sodium into adipocytes and hence a decrease in
Na-Ca2 exchange. Indeed, the activity of Na-H antiport of
thymocytes from CRF animals is impaired [35] and PTH inhibits
the Na-H activity of renal cells [36] and hepatocytes [37].
Fraser and Sarnacki [38] showed that the inosital 1,4,5-triphos-
phate (1P3) inhibited Na-Ca2 exchange in brain synaptosomes.
If PTH stimulates 1P3 production in adipocytes, one may expect
that the generated 1P3 would lead to inhibition of the Na-Ca2
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in Na-Ca2 exchange in CRF, it must be mentioned that a
similar abnormality was reported in cardiac myocytes [11] and in
hepatocytes [39] from rats with CRF.
The results of the present study may have important clinical
implications. The prevention or reversal of the elevation in
[Ca2Ji adipocytes in CRF may be associated with improvement
in the synthesis and/or release of lipases with consequent amelio-
ration of the hyperlipidemia of CRF. Indeed, Akmal et al [6]
showed that PTX of CRF rats or their treatment with verapamil
was followed by reversal of the increased calcium content of liver
and epidiymal fat, normalization of the post-heparin lipolytic
activity in plasma, hepatic lipase activity in liver homogenate,
removal of intravenous lipid load and consequently the hyperlip-
idemia. Thus, our data and those of Akmal et al [6] provide the
scientific rational for the examination of the effects of therapy
with calcium channel blocker on the hyperlipidemia of patients
with CRF.
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